C12N 2730/10162
By genetic engineering
Official title: by genetic engineering
C12N2730/10162 (By genetic engineering) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 5
- Inventors
- 9
- Latest grant
- 13 Aug 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year.
Recent patents
- Hepatitis b virus (hbv) knockouts24 Oct 2024US 2024/0350665 A1EmendoBio Inc.
- Compositions and methods for treating hepatitis b virus infection5 Sep 2024US 2024/0294914 A1Beam Therapeutics Inc.
- SARS vaccine compositions and methods of making and using them23 Jun 2011US 2011/0150929 A1Eli Lilly and Company
- SARS Vaccine Compositions and Methods of Making and Using Them15 Jan 2009US 2009/0017069 A1Lipid Sciences, Inc.
- Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases8 Feb 2007US 2007/0031923 A1Lipid Sciences, Inc.
Most cited
By later US patents